Table 1 Cohort characteristics.
From: Intrahepatic cholangiocarcinoma hidden within cancer of unknown primary
Liver involvement | No liver involvement | |||||
|---|---|---|---|---|---|---|
cCUP | iCCA | Primary tumour diagnosis | cCUP | Primary tumour diagnosis | ||
(N = 35) | (N = 24) | (N = 13) | (N = 116) | (N = 39) | ||
Gender | Female | 15 (43%) | 18 (75%) | 4 (31%) | 47 (41%) | 28 (72%) |
Male | 20 (57%) | 6 (25%) | 9 (69%) | 69 (59%) | 11 (28%) | |
ECOG performance status | 0 | 2 (6%) | 3 (13%) | 2 (15%) | 13 (11%) | 7 (18%) |
1 | 13 (37%) | 6 (25%) | 6 (46%) | 46 (40%) | 16 (41%) | |
2 | 12 (34%) | 6 (25%) | 4 (31%) | 20 (17%) | 11 (28%) | |
3 | 6 (17%) | 8 (33%) | 1 (8%) | 28 (24%) | 5 (13%) | |
4 | 2 (6%) | 1 (4%) | 0 | 9 (8%) | 0 | |
Age | Mean | 69 | 63 | 68 | 69 | 70 |
Range | 36–84 | 31–79 | 29–82 | 26–93 | 44–87 | |
MDT discussions | Any MDT | 35 (100%) | 24 (100%) | 12 (92%) | 111 (96%) | 36 (92%) |
≥2 MDTs | 19 (54%) | 12 (50%) | 7 (54%) | 71 (61%) | 24 (62%) | |
CUP MDT | 25 (71%) | 22 (92%) | 9 (69%) | 82 (71%) | 22 (56%) | |
HPB MDT | 10 (29%) | 9 (36%) | 3 (23%) | 5 (4%) | 0 | |
